Learn More
OBJECTIVES We evaluated the efficacy and safety of long-acting risperidone for 48-week period in Korean patients. METHODS This was a non-randomized, open-label, single-centered, 48-week study. Each of the participants visited the hospital every 2 weeks, and injections were given at each visit. Complete evaluations were done on five occasions (baseline,(More)
  • 1